TORRENT PHARMACEUTICALS L (TORNTPHARM) financials

TORRENT PHARMACEUTICALS L (TORNTPHARM) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.[1]It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.[2]

Market Cap: ₹1,74,208Cr.
Current Price: ₹4,580
Stock P/E: 84.9
ROE: 27.6%
ROCE: 19.8%
Book Value: ₹250
Dividend Yield: 0.83%
52W High / Low: ₹5,250/3,506

In Jun 2026, TORRENT PHARMACEUTICALS L (TORNTPHARM) reported sales ₹4,158 Cr and net profit ₹492 Cr.

Annual TTM: sales ₹12,964 Cr, net profit ₹1,975 Cr.

Shareholding: Promoters 60.78% (Jul 2026), FIIs 17.97% (Jul 2026), DIIs 12.77% (Jul 2026), Government 0.09% (Jul 2026), Public 8.39% (Jul 2026).

TORNTPHARM quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	2,434	2,377	2,433	2,616	2,762	2,599	3,445	4,158
Expenses	1,513	1,490	1,565	1,637	1,690	1,599	2,217	2,585
Operating Profit	921	887	868	979	1,072	1,000	1,228	1,573
OPM %	38%	37%	36%	37%	39%	38%	36%	38%
Other Income	-7	3	-9	-5	-40	-18	-96	-42
Interest	54	48	47	45	37	34	226	293
Depreciation	190	191	190	187	189	191	490	575
Profit before tax	670	651	622	742	806	757	416	663
Tax %	31%	26%	24%	26%	26%	24%	26%	26%
Net Profit	460	485	474	551	597	577	309	492
EPS in Rs	13.59	14.33	14.01	16.28	17.64	17.05	9.13	14.54
Raw PDF	—	—	—	—	—	—	—	—

TORNTPHARM profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	6,168	6,451	6,742	7,695	8,533	9,682	10,712	12,964
Expenses	4,251	4,259	4,642	5,230	5,644	6,107	6,659	8,091
Operating Profit	1,917	2,192	2,101	2,465	2,889	3,576	4,053	4,873
OPM %	31%	34%	31%	32%	34%	37%	38%	38%
Other Income	237	118	204	82	91	7	-52	-196
Interest	430	334	236	298	303	213	341	590
Depreciation	607	610	602	672	761	759	764	1,445
Profit before tax	1,117	1,366	1,466	1,577	1,917	2,610	2,897	2,642
Tax %	16%	17%	32%	33%	29%	28%	24%	—
Net Profit	939	1,138	991	1,051	1,357	1,888	2,192	1,975
EPS in Rs	27.73	33.62	29.30	31.07	40.10	55.79	64.75	58.36
Dividend Payout %	58%	52%	82%	71%	70%	57%	59%	—

TORNTPHARM balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	85	85	85	85	169	169	169	169
Reserves	4,931	5,036	5,945	6,261	6,287	6,660	7,423	8,283
Borrowings	5,623	5,294	4,404	3,348	4,575	3,344	2,629	14,277
Other Liabilities	1,389	1,469	1,327	1,460	1,840	2,204	2,620	3,085
Total Liabilities	12,027	11,884	11,761	11,153	12,872	12,377	12,842	25,814
Fixed Assets	7,425	7,198	6,741	6,251	7,972	7,986	7,554	7,370
CWIP	498	536	588	568	698	226	402	420
Investments	486	135	314	368	361	463	523	13,172
Other Assets	3,618	4,016	4,118	3,966	3,841	3,701	4,363	4,851
Total Assets	12,027	11,884	11,761	11,153	12,872	12,377	12,842	25,814

TORNTPHARM cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	1,232	1,580	1,573	2,140	2,265	2,893	2,574	2,731
Cash from Investing Activity	-373	269	-316	-160	-2,326	-296	-470	-12,990
Cash from Financing Activity	-928	-1,555	-1,581	-1,977	81	-2,578	-2,104	10,225
Net Cash Flow	-69	294	-325	3	20	19	-0	-34
Free Cash Flow	618	1,236	1,371	2,035	1,850	2,580	2,146	2,262
CFO/OP	89%	93%	81%	113%	103%	111%	86%	85%

TORNTPHARM shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Jul 2026
Promoters	68.31%	68.31%	68.31%	68.31%	68.31%	68.31%	68.31%	60.78%
FIIs	16.17%	16.31%	16.09%	15.92%	16.13%	16.18%	15.44%	17.97%
DIIs	8.25%	8.25%	8.54%	9.17%	9.05%	8.96%	9.73%	12.77%
Government	0.10%	0.10%	0.10%	0.10%	0.10%	0.00%	0.10%	0.09%
Public	7.17%	7.02%	6.93%	6.47%	6.41%	6.55%	6.42%	8.39%
No. of Shareholders	85,035	86,005	81,856	78,226	76,214	83,811	85,776	1,40,599

TORNTPHARM key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	86	89	87	83	82	67	82	90
Inventory Days	321	336	418	344	273	268	254	241
Days Payable	138	152	142	119	104	130	125	127
Cash Conversion Cycle	269	273	364	308	251	205	211	204
Working Capital Days	5	2	76	75	10	22	43	3
ROCE %	13%	14%	16%	17%	18%	21%	28%	20%

TORNTPHARMUpdated 15 Oct 2026, 4:49

Torrent Pharmaceuticals L

TORNTPHARMUpdated 15 Oct 2026, 4:49

Market Cap

₹1,74,208Cr.

Current Price

₹4,580

High / Low

₹5,250/3,506

Stock P/E

84.9

ROE27.6%

ROCE19.8%

Book Value₹250

Face Value₹5.00

Dividend Yield0.83%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	2121	90	1384	11	183	475	32	323	9.54
Sep 2023	2146	77	1410	15	192	482	32	327	9.66
Dec 2023	2123	69	1422	-11	191	430	31	297	8.78
Mar 2024	2143	67	1427	76	195	530	23	410	12.11
Jun 2024	2438	64	1539	21	189	667	30	469	13.86
Sep 2024	2434	54	1513	-7	190	670	31	460	13.59
Dec 2024	2377	48	1490	3	191	651	26	485	14.33
Mar 2025	2433	47	1565	-9	190	622	24	474	14.01
Jun 2025	2616	45	1637	-5	187	742	26	551	16.28
Sep 2025	2762	37	1690	-40	189	806	26	597	17.64
Dec 2025	2599	34	1599	-18	191	757	24	577	17.05
Mar 2026	3445	226	2217	-96	490	416	26	309	9.13
Jun 2026	4158	293	2585	-42	575	663	26	492	14.54

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	3468	173	2624	306	180	796	22	623	18.42
Mar 2016	5439	180	2990	292	213	2348	26	1743	51.51
Mar 2017	4551	202	3424	300	269	955	11	854	25.24
Mar 2018	4244	294	3337	332	384	562	14	482	14.24
Mar 2019	5762	481	4149	382	579	935	20	745	22.03
Mar 2020	6168	430	4251	237	607	1117	16	939	27.73
Mar 2021	6451	334	4259	118	610	1366	17	1138	33.62
Mar 2022	6742	236	4642	204	602	1466	32	991	29.3
Mar 2023	7695	298	5230	82	672	1577	33	1051	31.07
Mar 2024	8533	303	5644	91	761	1917	29	1357	40.1
Mar 2025	9682	213	6107	7	759	2610	28	1888	55.79
Mar 2026	10712	341	6659	-52	764	2897	24	2192	64.75
TTM	12964	590	8091	-196	1445	2642	—	1975	58.36

Shareholding pattern

As of Jul 2026%

Holder	Share
Promoters	60.78%
FIIs	17.97%
DIIs	12.77%
Government	0.09%
Public	8.39%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2023	71.25%	14.08%	7.11%	0.1%	7.46%
Mar 2024	71.25%	14.14%	7.15%	0.1%	7.34%
Jun 2024	71.25%	14.22%	7.17%	0.1%	7.25%
Sep 2024	71.25%	14.46%	6.98%	0.1%	7.21%
Dec 2024	68.31%	16.17%	8.25%	0.1%	7.17%
Mar 2025	68.31%	16.31%	8.25%	0.1%	7.02%
Jun 2025	68.31%	16.09%	8.54%	0.1%	6.93%
Sep 2025	68.31%	15.92%	9.17%	0.1%	6.47%
Dec 2025	68.31%	16.13%	9.05%	0.1%	6.41%
Mar 2026	68.31%	16.18%	8.96%	0%	6.55%
Jun 2026	68.31%	15.44%	9.73%	0.1%	6.42%
Jul 2026	60.78%	17.97%	12.77%	0.09%	8.39%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	85	2621	2521	1270	6497	2764	628	434	2672	6497
Mar 2016	85	3623	2249	1332	7289	2681	984	918	2705	7289
Mar 2017	85	4369	2446	1152	8051	3523	473	936	3119	8051
Mar 2018	85	4472	5845	1419	11820	7429	447	625	3319	11820
Mar 2019	85	4931	5623	1389	12027	7425	498	486	3618	12027
Mar 2020	85	5036	5294	1469	11884	7198	536	135	4016	11884
Mar 2021	85	5945	4404	1327	11761	6741	588	314	4118	11761
Mar 2022	85	6261	3348	1460	11153	6251	568	368	3966	11153
Mar 2023	169	6287	4575	1840	12872	7972	698	361	3841	12872
Mar 2024	169	6660	3344	2204	12377	7986	226	463	3701	12377
Mar 2025	169	7423	2629	2620	12842	7554	402	523	4363	12842
Mar 2026	169	8283	14277	3085	25814	7370	420	13172	4851	25814

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	1065	-2099	996	-38
Mar 2016	2403	-584	-1326	493
Mar 2017	676	-527	-130	19
Mar 2018	929	-4207	2929	-349
Mar 2019	1232	-373	-928	-69
Mar 2020	1580	269	-1555	294
Mar 2021	1573	-316	-1581	-325
Mar 2022	2140	-160	-1977	3
Mar 2023	2265	-2326	81	20
Mar 2024	2893	-296	-2578	19
Mar 2025	2574	-470	-2104	0
Mar 2026	2731	-12990	10225	-34

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	124	61	82	95	86	89	87	83	82	67	82	90
Inventory Days	263	299	272	425	321	336	418	344	273	268	254	241
Days Payable	212	205	144	254	138	152	142	119	104	130	125	127
Cash Conversion Cycle	175	155	209	267	269	273	364	308	251	205	211	204
Working Capital Days	109	53	120	10	5	2	76	75	10	22	43	3
ROCE %	22%	44%	17%	9%	13%	14%	16%	17%	18%	21%	28%	20%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of TORRENT PHARMACEUTICALS L (TORNTPHARM)?

The reported market capitalisation for TORRENT PHARMACEUTICALS L (TORNTPHARM) is ₹1,74,208Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of TORNTPHARM?

The current price shown for TORRENT PHARMACEUTICALS L (TORNTPHARM) on Fincrux is ₹4,580 with a 52-week high/low of ₹5,250/3,506.

What is the P/E ratio of TORRENT PHARMACEUTICALS L (TORNTPHARM)?

The stock P/E for TORRENT PHARMACEUTICALS L (TORNTPHARM) is 84.9 on Fincrux, with ROE at 27.6% and ROCE at 19.8%.

What were TORNTPHARM latest quarterly results?

For Jun 2026, TORRENT PHARMACEUTICALS L (TORNTPHARM) reported sales ₹4,158 Cr and net profit ₹492 Cr (figures in ₹ crore unless noted).

What are TORNTPHARM annual sales and net profit?

For TTM, TORRENT PHARMACEUTICALS L (TORNTPHARM) shows sales of ₹12,964 Cr and net profit of ₹1,975 Cr on the Fincrux profit & loss statement.

Who owns TORRENT PHARMACEUTICALS L (TORNTPHARM)?

Latest shareholding for TORRENT PHARMACEUTICALS L (TORNTPHARM) on Fincrux: Promoters 60.78% (Jul 2026), FIIs 17.97% (Jul 2026), DIIs 12.77% (Jul 2026), Government 0.09% (Jul 2026), Public 8.39% (Jul 2026).

Where can I find TORRENT PHARMACEUTICALS L (TORNTPHARM) financials?

TORRENT PHARMACEUTICALS L (TORNTPHARM) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show TORNTPHARM balance sheet and cash flow?

Yes. The TORRENT PHARMACEUTICALS L (TORNTPHARM) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 15 October 2026 at 4:49